GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/GI Surgery/Liver Margin Status in pCCA : Ann Surg | May 2026
43

Liver Margin Status in pCCA : Ann Surg | May 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated May 1, 2026

Introduction

Achieving margin-negative resection remains one of the major determinants of long-term outcomes in perihilar cholangiocarcinoma (pCCA). While proximal and distal ductal margins are routinely evaluated, the liver margin (LM) represents the largest and least standardized resection margin in pCCA surgery. This multicenter study investigated the prevalence, spatial distribution and prognostic significance of LM positivity using serial whole-mount digital large-section (WDLS) pathology.

Problem Statement

Among 227 patients undergoing major hepatectomy for pCCA, WDLS-based assessment identified LM R1 resection in 38.6% of cases, substantially higher than conventional small-section analysis alone. Standard pathology underestimated positive LM involvement, detecting only approximately 6% of R1 cases. Importantly, patients classified as true R0 by WDLS demonstrated superior overall survival and recurrence-free survival compared with conventionally assessed controls. Spatial mapping revealed that 95% of carcinoma involvement occurred within 20 mm of the proximal ductal margin (P-DM), and a P-DM distance <5 mm independently predicted LM positivity.

Summary

This study establishes liver margin positivity as a major contributor to occult R1 resection in pCCA and demonstrates that conventional sampling substantially underestimates residual microscopic disease. WDLS significantly improved diagnostic accuracy and refined pathological risk stratification. The authors propose a practical LM assessment strategy focused on systematic examination within a 20 mm radius surrounding the proximal ductal margin, particularly in patients with a P-DM distance <5 mm. These findings may redefine pathological evaluation standards in pCCA and improve surgical quality assessment, prognostication and postoperative management.

Related Q&A

44

Early-Onset Pancreatic Cancer Shows Aggressive Molecular Biology : Br J Surg | May 2026

Introduction The global rise in early-onset gastrointestinal malignancies has become a major oncologic concern, with pancreatic ductal adenocarcinoma (PDAC) increasingly being diagnosed in patients younger than 50 years....

45

Financial Toxicity After Complex GI Surgery : Ann Surg | May 2026

Introduction Financial toxicity (FT) has emerged as an important yet underrecognized consequence of modern cancer care. Patients undergoing major gastrointestinal (GI) surgery frequently face substantial economic stress related...

46

Minimally Invasive Surgery Provides Durable Relief in Thoracic Esophageal Diverticula : Journal of Gastrointestinal Surgery | May 2026

Introduction Mid- and distal thoracic esophageal diverticula are uncommon but clinically significant disorders that frequently present with dysphagia, regurgitation and aspiration-related symptoms. Surgical management has evolved substantially over...

47

Robotic Groin Hernia Repair Shows No Long-Term Recurrence Advantage | JAMA Surgery

Introduction Robotic-assisted groin hernia repair has rapidly expanded across surgical practice in the United States, driven by increasing adoption of minimally invasive techniques and perceived technical advantages such...

48

Younger Adults Face Higher Intra-Abdominal Risk After Colectomy for Diverticular Disease | Journal of Gastrointestinal Surgery

Introduction Diverticular disease has traditionally been considered a condition of older adults, but its incidence in younger populations has risen substantially over recent decades. As colectomy is increasingly...

49

Robot-Assisted Esophagectomy vs Conventional MIE: Annals of Surgical Oncology | April 2026

Introduction Surgical management of Esophageal cancer continues to evolve, with minimally invasive techniques improving perioperative outcomes. A newer concept—total mesoesophageal excision (TME)—aims to enhance oncologic clearance. The integration...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer